Ivan D. Horak
2009
In 2009, Ivan D. Horak earned a total compensation of $730.2K as Former President, Research and Development and Chief Scientific Officer at Enzon Pharmaceuticals, a 48% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $162,500 |
|---|---|
| Salary | $533,663 |
| Other | $34,028 |
| Total | $730,191 |
Horak received $533.7K in salary, accounting for 73% of the total pay in 2009.
Horak also received $162.5K in non-equity incentive plan and $34K in other compensation.
Rankings
In 2009, Ivan D. Horak's compensation ranked 5,518th out of 9,885 executives tracked by ExecPay. In other words, Horak earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,518 out of 9,885 | 44th |
Division Manufacturing | 1,982 out of 3,690 | 46th |
Major group Chemicals And Allied Products | 411 out of 866 | 53rd |
Industry group Drugs | 264 out of 638 | 59th |
Industry Biological Products, Except Diagnostic Substances | 46 out of 133 | 65th |
Source: SEC filing on April 8, 2011.
Horak's colleagues
We found five more compensation records of executives who worked with Ivan D. Horak at Enzon Pharmaceuticals in 2009.
2009
Jeffrey Buchalter
Enzon Pharmaceuticals
Chief Executive Officer
2009
Craig Tooman
Enzon Pharmaceuticals
Chief Financial Officer
2009
Ralph del Campo
Enzon Pharmaceuticals
Chief Operating Officer
2009
Paul Davit
Enzon Pharmaceuticals
Executive Vice President, Human Resources and Administration
2009
Mark Ogden
Enzon Pharmaceuticals